Casado M, Boscá L, Martín-Sanz P
Facultad de Farmacia, Instituto de Bioquímica, Consejo Superior de Investigaciones Científicas-Universidad Complutense, Madrid, Spain.
Am J Physiol. 1996 Feb;270(2 Pt 1):E244-50. doi: 10.1152/ajpendo.1996.270.2.E244.
Fetal rat liver expresses a 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/Fru-2,6-Pase2) form that differs from the adult liver enzyme in the inhibition by phosphorylation by the adenosine 3',5'-cyclic monophosphate-dependent protein kinase and in the recognition by an antibody specific for the NH2-terminal domain of the adult liver enzyme. Northern blot analysis shows that fetal hepatocytes contain a species of mRNA that is 2.2 kb in size and that exhibits the maximal levels after delivery. PFK-2/Fru-2,6-Pase2 mRNA analysis using a sensitive ribonuclease protection assay reveals the presence of nearly similar amounts of adult liver-specific and skeletal muscle-specific mRNA in fetal liver and hepatocytes during the last days of gestation, as well as a 233-bp protected fragment present in fetal liver. These results were confirmed by polymerase chain reaction using specific oligonucleotide pairs. Primer extension of fetal liver cDNA suggests the presence of two initiation sites of transcription. Analysis of the adult liver PFK-2/Fru-2,6-Pase2 protein during the perinatal transition using a specific antibody shows a marked accumulation of this form immediately after birth.
胎鼠肝脏表达一种6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶(PFK-2/Fru-2,6-Pase2)形式,它与成年肝脏酶的不同之处在于,它受3',5'-环磷酸腺苷依赖性蛋白激酶磷酸化的抑制作用,以及被一种对成年肝脏酶NH2末端结构域具有特异性的抗体识别的情况。Northern印迹分析表明,胎肝细胞含有一种大小为2.2 kb的mRNA,且在出生后呈现出最高水平。使用灵敏的核糖核酸酶保护试验对PFK-2/Fru-2,6-Pase2 mRNA进行分析,发现在妊娠最后几天,胎肝和肝细胞中存在几乎等量的成年肝脏特异性和骨骼肌特异性mRNA,以及胎肝中存在一个233 bp的受保护片段。使用特定寡核苷酸对进行的聚合酶链反应证实了这些结果。胎肝cDNA的引物延伸表明存在两个转录起始位点。使用特异性抗体对围产期过渡期间成年肝脏PFK-2/Fru-2,6-Pase2蛋白进行分析,结果显示这种形式在出生后立即有明显积累。